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ABSTRACT
Objective: Reversed-phase high-performance liquid chromatographic method (RP-HPLC) was developed for the assessment of lopinavir in the 
dosage form of tablet.
Methods: Chromatogram was run through using Kromosil C18 4.5×150 mm using a mobile phase methanol: water of ratio 65:35% v/v with a rate of 
flow of 0.8 ml/min, measured by UV spectrometric detection at 265 nm. The method developed was validated in terms of precision, accuracy, linearity, 
and robustness parameters.
Results: Retention time of lopinavir established at 2.482 min and percentage R.S.D of lopinavir found to be 1.0% and 0.5%, respectively. The method 
shows that good linearity range of 30–150 µg correlation coefficient of lopinavir was 0.997. The limit of detection was 2.97 and limit of quantification 
was 9.92, respectively. The percent purity of lopinavir was 99.87%.
Conclusion: The suggested method (Rp-HPLC) for concurrent assay lopinavir was validated, which is appropriate method for the analysis of lopinavir 
quantitatively in tablet dosage forms and bulk.
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INTRODUCTION
The selected drug lopinavir is a white to light (tan) powder, in water 
practically insoluble, but in methanol, it is freely soluble [1]. It is an anti-
HIV, anti-infective, and antiretroviral agents [2]. Lopinavir inhibits the 
HIV viral protease enzyme. Detailed literature survey for the lopinavir 
determination in formulations and bulk drug revealed several methods 
that have been reported for the assay of it either alone or in combined 
dosage forms such as high-performance liquid chromatography 
(HPLC)  [3-11] and UV spectrophotometric methods [12-17].
The development and validation of an analytical method is to ensure 
a specific, accurate, and precise method for a particular drug with an 
objective to enhance the conditions and parameters. From the literature 
survey that the reversed-phase HPLC (RP-HPLC) methods were not 
reported in the estimation of lopinavir. Thus, the present research 




Waters, separation module 2695, PDA detector Instrument with 
Kromosil C18 column 4.5×150 mm and HPLC - auto sampler - UV 
detector using Empower software version-2 and Lab India U.V double 
beam spectrometer of UV 3000+ model and U.V win software were 
used. HPLC grade water, methanol, acetonitrile, orthophosphoric 
acid, and KH2PO4K2HPO4 were procured from Merck Enterprises, 
India.
Lead of solutions and reagents
Standard solution preparation
About 10 mg of standard sample was weighed accurately, added to a 
volumetric flask of 10 ml capacity, and added 7 ml of diluents, dissolved 
completely by sonication and with stock solution the volume made 
up to the mark. To a volumetric flask of 10 ml capacity, 0.9 ml of stock 
solution was added and the solution was diluted to the mark using 
diluents.
Preparation of sample solution
To a 10 ml volumetric flask added accurately weighed 10 mg equivalent 
of lopinavir capsule powder, 1 ml of diluents was added, dissolved 
completely by sonication and with stock solution the volume made up 
to the mark. 1 ml of the prepared stock solution stated above was added 
to a volumetric flask of 10 ml capacity, and using diluents, the solution 
was diluted up to the mark.
Methodology
The chromatographic system was injected with about 20 µL of the blank 
solution, sample solution, and standard solution each, and lopinavir 
peak area was calculated.
Process validation
The proposed HPLC process validated in accordance of the ICH 
guidelines with aspect to accuracy, linearity, precision, specificity, 
limit of quantification (LOQ), robustness, and limit of detection 
(LOD) [10].
Linearity
The standard stock solution for both the drugs prepared individually 
by diluting to obtain the five standard solutions in the concentration 
of linearity range of 30–150 µg for lopinavir. About 20 µl volume was 
injected and run under above referred chromatographic conditions. 
From the values of peak area versus the concentration (µg/ml), linear 
regressions of lopinavir were executed. Linearity was checked with 
correlation coefficient and calibration curve.
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Accuracy
The fidelity method was committed in solutions made of various 
concentrations of lopinavir, that is, 50%, 100%, and 150%, the quantity 
of sample lopinavir is kept constant and amount of pure drug was 
varied in terms such as 5 mg, 10 mg, and 15 mg in case of lopinavir, 
i.e., 50%, 100%, and 150%, respectively.
Repeatability, LOD, and LOQ [4,7]
Assay preparation on same day during intraday precision (repeatability) 
was resolved by replicate analysis (n=3); intermediate precision 
was checked on 3 consecutive days for replicate analysis of the given 
solutions. Assay precisions were conveyed as relative standard deviation.




Hence, y-intercept gives standard deviation and S is slope of line.
The LOQ was calculated as follows [3,7]:
DLOQ = 10×
S
LOD and LOQ concentrations of test solution were injected 6 times in 
the chromatograph and R.S.D. percent was measured from the peak 
area of replicate injections.
Robustness
The precision study was performed for five injections of lopinavir. Each 
standard injection was injected in to chromatographic system.
The area of each Standard injection was used for calculation of % RSD.
As the part of the method validation robustness, the impact of flow rate 
change deliberately and the mobile phase composition change with the 
method was evaluated [4].
a. Lopinavir standard solution 90 ppm was prepared and by 
varying flow rates (0.8–1.2 ml/min) along with flow rate method 
analyzed  [6].
b. Lopinavir standard solution 90 ppm was prepared and analyzed by 
varying mobile phase composition from 75% to 55% along with the 
actual mobile phase.
System suitability
To 10 ml volumetric flask added 10 mg of lopinavir standard sample 
by weighing accurately and sonicated by adding 7 ml of diluent, using 
stock solution, the volume makes up to the mark. To volumetric flask 
of 10 ml capacity added 0.9 ml lopinavir from the above stock solution, 
and using diluent, the solutions were diluted up to the mark.
RESULTS AND DISCUSSION
The suggested method originated as mere, specific, precise, and 
accurate for the routine estimation of drugs simultaneously. Several 
mobile phases with dissimilar solvents in varied proportions tried 
to resolve the drug peaks with fair peak asymmetry, resolution, and 
number of theoretical plates. Finally, a mobile phase consisting of 
65:35% v/v methanol: water was selected for analysis, which showed 
good resolution of lopinavir peak with a retention time of 2.482 min, and 
neither of the impurities was interfering in its assay. System suitability 
trails were accomplished to specify resolution, column (Fig. 1) efficacy, 
peak asymmetry, and tailing factor. For the proposed method, all the 
system suitability criteria were within the limits specified and findings 
are stated in Table 1.
Linearity
The correlation coefficient was calculated by plotting a graph with 
concentration in the X-axis and Y-axis peak area. It was found to be 0.999. 
Correlation coefficients, slopes, and y-intercepts of regression lines for 
the two substances were evaluated and results are incorporated in 
Table 2.
Accuracy
The percent recovery of lopinavir ranged out of 98.0–102.0%, 
respectively. Therefore, no interference from the additives commonly 
present in the tablets and developed technique constitute to be precise 
as the percent relative standard deviations for repeatability and 
intermediate precision is <2 as per proposed ICH guidelines. The value 
of 1.0% for lopinavir indicates good repeatability of the method. The 
recovery studies data are stated in Table 3.
LOD and LOQ
LOD for lopinavir was 2.97 and LOQ for lopinavir is 9.92 g/mL and 
10.02 g/mL, respectively.
Precision
The %RSD of Lopinavir was found to be 0.15 (Table 4). %RSD values of 
peak area found to be less than 2.0. Hence the optimized method was 
found to be precise as per ICH guidelines Q2 (R1).
Robustness
The robustness considerate varied chromatographic conditions, the 
retention time and peak asymmetry of the two drug peaks were not 
significantly influenced by the low standard deviation values (below 
2)for each criterion. Thus, the developed LC method was robust in 
the findings of lopinavir in combined tablet dosage formulations 
Table 5.
System suitability
Accurate amount of 10 mg lopinavir standard was weighed and the 
standard drug was transferred to volumetric flask of 10 ml capacity, 
sonicated after adding diluent of about 7 ml to dissolve the components 
and stock solution added to make volume up to the mark. Pipetted 
0.9 ml of the prepared stock solution stated above to standard flask of 
10 ml capacity and diluted using diluent up to the mark.
Assay
The proposed technique was applied in terms of assay for commercial 
formulation by injecting the blank solution, standard solution, and 
sample solution of 20 µL each into the chromatographic system. The 
percentage of lopinavir was calculated from the peak areas. The percent 
purity of lopinavir was found to be 99.87%. The assay findings and label 
Table 1: System suitability parameters for lopinavir
System suitability parameter Lopinavir
Retention time (min) (mean±S.D., n=5) 2.428
Tailing factor (peak asymmetry) 0.87
Theoretical plates 4024







Coefficient of correlation (R2) 0.997
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claim of the substance had good agreement between them. This implies 
the disposition of drug in tablet dosage form was steady without 
significant variation. The result of estimation is presented in Table 6.
Result analysis of tablet formulation
Liquid chromatographic method was developed in this study determine 
the lopinavir amount in combined tablet dosage forms. The total 
chromatographic analysis time per sample was 5 min with respect to 
the lopinavir retention time established at 2.482 min and percentage 
R.S.D. of lopinavir found to be 1.0% and 0.5%, respectively.
CONCLUSION
For concurrent assay of lopinavir, method suggested (RP-HPLC) was 
validated and it was an appropriate method for routine analysis of 
lopinavir quantitatively in dosage forms and. The proposed technique 
is accurate, rapid, and sensitive. It makes the use of little quantities of 
solvents and changes the set of conditions requires in short intervals. It 
does not suffer from any hindrance due to common additives present 
in pharmaceutical dosage forms and can be readily accepted for quality 
control analysis.
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